Trial intelligence / Profile preview

CartiZol vs Hyaluronic Acid in Knee Osteoarthritis

NCT07511777Completed

Sponsor
Cellontech
Start
Feb 2024
Primary completion
Aug 2025
Countries
1
01

Overview

Randomised, double-blind trial of DPS-004 in osteoarthritis (OA) (2 arms), sponsored by Cellontech. Primary endpoint: Visual Analogue Scale for Pain at 52 weeks. Started Feb 2024; status: completed.

02

Drugs

DPS-004
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07511777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07511777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call